These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8604567)

  • 21. Cost analysis of PAPNET-assisted vs. conventional Pap smear evaluation in primary screening of cervical smears.
    Meerding WJ; Doornewaard H; van Ballegooijen M; Bos A; van der Graaf Y; van den Tweel JG; van der Schouw YT; Habbema JD
    Acta Cytol; 2001; 45(1):28-35. PubMed ID: 11213501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical validation of interactive cytologic screening. Automating the search, not the interpretation.
    Mango LJ
    Acta Cytol; 1997; 41(1):93-7. PubMed ID: 9022733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytology proficiency dilemma: the case for computer-based testing.
    Quarngesser SS
    Am Clin Lab; 1996; 15(10):18. PubMed ID: 10164049
    [No Abstract]   [Full Text] [Related]  

  • 25. Reproducibility in double scanning of cervical smears with the PAPNET system.
    Doornewaard H; van der Schouw YT; van der Graaf Y
    Acta Cytol; 2000; 44(4):604-10. PubMed ID: 10934954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Computer-assisted rescreening of cervicovaginal smears stained by the Papanicolaou method. Evaluation of the PAPNET system apropos of 225 cases].
    Vuong PN; Vacher-Lavenu MC; Marsan C; Baviera E
    Arch Anat Cytol Pathol; 1995; 43(3):147-53. PubMed ID: 7574913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
    Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
    Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer catcher. Neural net catches errors that slip through Pap tests.
    Rennie J
    Sci Am; 1990 May; 262(5):84. PubMed ID: 2333498
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the PAPNET system for prescreening triage of cervicovaginal smears.
    Ashfaq R; Saliger F; Solares B; Thomas S; Liu G; Liang Y; Saboorian MH
    Acta Cytol; 1997; 41(4):1058-64. PubMed ID: 9250299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAPNET-assisted primary screening of conventional cervical smears.
    Cenci M; Nagar C; Vecchione A
    Anticancer Res; 2000; 20(5C):3887-9. PubMed ID: 11268471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System.
    Patten SF; Lee JS; Nelson AC
    Acta Cytol; 1996; 40(1):45-52. PubMed ID: 8604574
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAPNET Testing System. Technical update.
    Denaro TJ; Herriman JM; Shapira O
    Acta Cytol; 1997; 41(1):65-73. PubMed ID: 9022728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of three new technologies to enhance Pap testing.
    Tecnologica MAP Suppl; 1998 Feb; ():40-1. PubMed ID: 10183360
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized crossover trial of PAPNET for primary cervical screening.
    Irwig L; Macaskill P; Farnsworth A; Wright RG; McCool J; Barratt A; Simpson JM
    J Clin Epidemiol; 2004 Jan; 57(1):75-81. PubMed ID: 15019013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labeling liquid-based systems: FDA clarification.
    Gutman S
    Acta Cytol; 2000; 44(6):1120. PubMed ID: 11127746
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.